ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Medical Treatment of Hypercortisolism With Relacorilant: Final Resul…

Heart in Diabetes (HiD)

R. Pivonello

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Wegovy 2024 Updates

Susan Brian

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

CKD in Primary Care Full Webinar

Springer Healthcare IME

S. Seidu, B. Itzhak, M. Ungan, L. Moist

New Research: Side Effect of GLP1

Susan Brian

GI Side Effects of Ozempic/ Wegovy

Susan Brian

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Choosing the Optimal Blood Pressure Medication for My Hypertensive P…

Rivka Ayalon

An Introduction to Tirzepatide for Weightloss

Susan Brian

Physicial Activity and Cardiorespiratory Fitness as Modulators of He…

Barry A. Franklin

How to Prescribe Anti Obesity Medications

Beverly Tchang

The Role of Food Additives Based in Potassium, Phosphorus and Sodium…

Valeria Cecchini

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

Artificial Intelligence & CHAT GPT in Nephrology

University of Colorado Department of Medicine

S. Ambruso

Predictors of Poor Response to Semaglutide for Weight Management

Ploutarchos Tzoulis

Chapter 4 - How Can Primary Care Be Supported to Bridge the Chronic …

Springer Healthcare IME

S. Seidu, B. Itzhak, M. Ungan, L. Moist